Follow Health Care Reform Insider on Twitter
You are here:  Home  >  States  >  Current Article

Why one state wants to slow down use of a new hepatitis C cure

July 18, 2014 

In the ongoing battle over the $84,000 price tag of the new hepatitis C treatment Sovaldi, big news came out of Oregon this week — the state is advancing recommendations to limit the drug to only the sickest patients enrolled in its Medicaid program.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>